Dossier: Early Detection
Oncology care is becoming increasingly relevant for healthcare organizations and professionals. Overall cancer rates are increasing due to rising life expectancy and growing populations. In 2030, more than 21 million men and women worldwide could develop cancer – 50% more than in 2012.1 Because of the exponential growth in the number of patients and the related costs, it’s key to identify advances tailored to improve care and patient outcomes.
This dossier focuses on new screening approaches. In certain cases, early detection and early intervention can be the only way to avoid a manifest disease.2 Breast cancer screening has become internationally established, despite many controversies, and is currently being further developed using methods such as tomosynthesis, whereas lung cancer screening using low-dose CT still has to pass long-term testing in the field.
1International Agency for Research on Cancer, Globocan 2012: http://globocan.iarc.fr/Pages/burden_sel.aspx (accessed 8 May 2017)
2Tomasetti C, Li L, Vogelstein B (2017) Stem cell divisions, somatic mutations, cancer etiology, and cancer prevention. Science 355:1330-1334